secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2026-06-23T14:09:39+00:00
Accession:  0001193125-26-278642
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics stockholders re-elect Garo Armen, Barbara Ryan, John Holcomb as directors; ratify KPMG
--------------------------------------------------------------------------------

- Quorum of 3,277,906 shares (65.79% of outstanding) present at annual meeting.
- All three Class II director nominees elected: Garo Armen (2,363,360 for), Barbara Ryan (2,362,760 for), John Holcomb (2,381,491 for).
- Ratification of KPMG as independent auditor for 2026 approved: 3,249,124 for, 26,560 against, 2,222 abstain.
- Broker non-votes of 881,648 on director election; no broker non-votes on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000119312526278642/0001193125-26-278642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000119312526278642/inkt-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-278642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer